Cargando…

17p deletion strongly influences rituximab elimination in chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) is the most common type of leukemia and the anti-CD20 monoclonal antibody, rituximab, represents the therapeutic gold standard for more than 2 decades in this pathology, when used in combination with chemotherapy. However, some patients experience treatment resista...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bagacean, Cristina, Tempescul, Adrian, Ternant, David, Banet, Anne, Douet-Guilbert, Nathalie, Bordron, Anne, Bendaoud, Boutahar, Saad, Hussam, Zdrenghea, Mihnea, Berthou, Christian, Paintaud, Gilles, Renaudineau, Yves
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352369/ https://www.ncbi.nlm.nih.gov/pubmed/30696487 http://dx.doi.org/10.1186/s40425-019-0509-0

Ejemplares similares

Combining cytogenetic and epigenetic approaches in chronic lymphocytic leukemia improves prognosis prediction for patients with isolated 13q deletion
por: Bagacean, Cristina, et al.
Publicado: (2017)

Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy
por: Bordron, Anne, et al.
Publicado: (2018)

Alterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemia
por: Bagacean, Cristina, et al.
Publicado: (2017)

Rapid and complete response to idelalisib in a case of Richter syndrome
por: Bagacean, Cristina, et al.
Publicado: (2019)

DNA demethylation marks in chronic lymphocytic leukemia: it is time to let the cat out of the bag
por: Bagacean, Cristina, et al.
Publicado: (2017)

ESHAP chemotherapy is efficient in refractory/relapsed primary central nervous system lymphoma: report of four cases
por: Ungur, Rodica, et al.
Publicado: (2015)

Homozygous FCGR3A-158F mutation is associated with delayed B-cell depletion following rituximab but with preserved efficacy in a patient with refractory lupus nephritis
por: Seret, Guillaume, et al.
Publicado: (2013)

Exudative pericarditis in the evolution of a diffuse large B-cell lymphoma
por: Bagacean, Cristina, et al.
Publicado: (2015)

Atypical aleukemic presentation of large granular lymphocytic leukemia: a case report
por: Bagacean, Cristina, et al.
Publicado: (2016)

Immune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies
por: Ilcus, Cristina, et al.
Publicado: (2017)

MicroRNAs Associated With a Good Prognosis of Acute Myeloid Leukemia and Their Effect on Macrophage Polarization
por: Neaga, Alexandra, et al.
Publicado: (2021)

STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia
por: Debant, Marjolaine, et al.
Publicado: (2019)

Simulated patient and role play methodologies for communication skills and empathy training of undergraduate medical students
por: Bagacean, Cristina, et al.
Publicado: (2020)

Exopolysaccharides Isolated from Hydrothermal Vent Bacteria Can Modulate the Complement System
por: Courtois, Anthony, et al.
Publicado: (2014)

A new approach to comparing anti-CD20 antibodies: importance of the lipid rafts in their lytic efficiency
por: Hammadi, Mariam, et al.
Publicado: (2010)

Hyposialylation Must Be Considered to Develop Future Therapies in Autoimmune Diseases
por: Bordron, Anne, et al.
Publicado: (2021)

Floridoside Extracted from the Red Alga Mastocarpus stellatus Is a Potent Activator of the Classical Complement Pathway
por: Courtois, Anthony, et al.
Publicado: (2008)

Hemorrhagic Cystitis due to BK Reactivation in a Young Female Treated for Hodgkin-Disease
por: Le Calloch, R., et al.
Publicado: (2011)

Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative study
por: Mulleman, Denis, et al.
Publicado: (2011)

JAK Inhibitors and Oxidative Stress Control
por: Charras, Amandine, et al.
Publicado: (2019)

An in silico Approach Reveals Associations between Genetic and Epigenetic Factors within Regulatory Elements in B Cells from Primary Sjögren’s Syndrome Patients
por: Konsta, Orsia D., et al.
Publicado: (2015)

The fragility index in 2010-2021 chronic lymphocytic leukemia randomized controlled trials
por: Bagacean, Cristina, et al.
Publicado: (2022)

Revisiting myocardial necrosis biomarkers: assessment of the effect of conditioning therapies on infarct size by kinetic modelling
por: Ternant, David, et al.
Publicado: (2017)

Infection by H1N1 flu virus revealing T-cell acute lymphoid leukaemia: about two cases
por: Lefevre, Guillaume, et al.
Publicado: (2010)

Kinetic modelling of myocardial necrosis biomarkers offers an easier, reliable and more acceptable assessment of infarct size
por: Chadet, Stéphanie, et al.
Publicado: (2020)

Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases
por: Ducourau, Emilie, et al.
Publicado: (2011)

Abnormal B cell glycosylation in autoimmunity: A new potential treatment strategy
por: Morel, Marie, et al.
Publicado: (2022)

Xanthine oxidase inhibitors in ischaemic heart disease
por: Zdrenghea, Mihnea, et al.
Publicado: (2017)

Association of IgG1 Antibody Clearance with FcγRIIA Polymorphism and Platelet Count in Infliximab-Treated Patients
por: Thibault, Gilles, et al.
Publicado: (2021)

RBM22, a Key Player of Pre-mRNA Splicing and Gene Expression Regulation, Is Altered in Cancer
por: Soubise, Benoît, et al.
Publicado: (2022)

Cytogenetic and Genetic Abnormalities with Diagnostic Value in Myelodysplastic Syndromes (MDS): Focus on the Pre-Messenger RNA Splicing Process
por: Douet-Guilbert, Nathalie, et al.
Publicado: (2022)

Acute dyspnoea and single tracheal localisation of mantle cell lymphoma
por: Ianotto, Jean-Christophe, et al.
Publicado: (2010)

Evolution of cardiovascular risk factors and ischemic heart disease in an elderly urban Romanian population over the course of 1 year
por: Pop, Dana, et al.
Publicado: (2013)

A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen
por: Lereclus, Emilie, et al.
Publicado: (2017)

Infliximab Efficacy May Be Linked to Full TNF-α Blockade in Peripheral Compartment—A Double Central-Peripheral Target-Mediated Drug Disposition (TMDD) Model
por: Ternant, David, et al.
Publicado: (2021)

Recombinant humanised anti-HER2/neu antibody (Herceptin®) induces cellular death of glioblastomas
por: Mineo, J-F, et al.
Publicado: (2004)

The Potential Equivalents of TET2 Mutations
por: Pasca, Sergiu, et al.
Publicado: (2021)

TET2/IDH1/2/WT1 and NPM1 Mutations Influence the RUNX1 Expression Correlations in Acute Myeloid Leukemia
por: Pasca, Sergiu, et al.
Publicado: (2020)

Plasmatic Levels of N-terminal Pro-BNP in Elderly Patients with Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction
por: ZĂGREANU, Vasile Mircea, et al.
Publicado: (2017)

Clonal evolution in UKE-1 cell line leading to an increase in JAK2 copy number
por: Buors, C, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_leekcq9i6bmbvbbdp6chnbssos